Ladanan, Brenda O.

HRN: 28-85-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CLINDAMYCIN 300MG (CAP)
04/12/2026
04/19/2026
PO
300MG
BID
NON HEALING WOUND
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: